Skip Navigation

European Heart Journal 2001 22(24):2221-2223; doi:10.1053/euhj.2001.2830
Copyright © 2001 by the European Society of Cardiology.
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Giugliano, R.P.
Right arrow Articles by Antman, E.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giugliano, R.P.
Right arrow Articles by Antman, E.M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Editorials

Caeteris paribus—all things being equal

R.P. Giugliano and E.M. Antman

Brigham and Women's Hospital, Boston, Mass, U.S.A

References

  1. N Engl J Med. 1997;337:1118–1123[Abstract/Free Full Text]
  2. Lancet. 1999;354:716–722[CrossRef][ISI][Medline]
  3. Eur Heart J. 2000;21:2005–2013[Abstract/Free Full Text]
  4. Ware JH, Antman EM. Equivalence trials. N Engl J Med. 1997;337:1159–1161[Free Full Text]
  5. Llevadot J, Giugliano RP, Antman EM. Bolus Fibrinolytic Therapy in Acute Myocardial Infarction. JAMA. 2001;:
  6. Mehta SR, Eikelboom JW, Yusuf S. Risk of intracranial haemorrhage with bolus versus infusion thrombolytic therapy: a meta-analysis. Lancet. 2000;356:449–454[CrossRef][ISI][Medline]
  7. Lancet. 1995;346:329–336[CrossRef][ISI][Medline]
  8. Van de Werf F, Barron HV, Armstrong PW. ncidence and predictors of bleeding events after fibrinolytic therapy with fibrin-specific agents: a comparison of TNK-tPA and rt-PA. Eur Heart J. 2001;22:2253–2261[Abstract/Free Full Text]
  9. N Engl J Med. 1993;329:673–682[Abstract/Free Full Text]
  10. Giugliano RP, Antman EM, McCabe CH. Omission of heparin bolus lowers rate of intracranial hemorrhage with lanoteplase. J Am Coll Cardiol. 2000;35:407A
  11. Simoons ML, Maggioni AP, Knatterud G. Individual risk assessment for intracranial haemorrhage during thrombolytic therapy. Lancet. 1993;342:1523–1528[CrossRef][ISI][Medline]
  12. White HD, Barbash GI, Modan M. After correcting for worse baseline characteristics, women treated with thrombolytic therapy for acute myocardial infarction have the same mortality and morbidity as men except for a higher incidence of hemorrhagic stroke. The Investigators of the International Tissue Plasminogen Activator/Streptokinase Mortality Study. Circulation. 1993;88:2097–2103[Abstract/Free Full Text]
  13. Giugliano RP, McCabe CH, Antman EM. Lower-dose heparin with fibrinolysis is associated with lower rates of intracranial hemorrhage. Am Heart J. 2001;141:742–750[CrossRef][ISI][Medline]
  14. Hochman JS, Wali AU, Gavrila D. A new regimen for heparin use in acute coronary syndromes. Am Heart J. 1999;138:313–318[CrossRef][ISI][Medline]
  15. N Engl J Med. 1997;336:1689–1696[Abstract/Free Full Text]

Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?



This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Giugliano, R.P.
Right arrow Articles by Antman, E.M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Giugliano, R.P.
Right arrow Articles by Antman, E.M.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?